Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May 1;66(Pt 5):575-8.
doi: 10.1107/S1744309110010857. Epub 2010 Apr 30.

Crystallization and preliminary X-ray analysis of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Staphylococcus aureus

Affiliations

Crystallization and preliminary X-ray analysis of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Staphylococcus aureus

Sandeep Chhabra et al. Acta Crystallogr Sect F Struct Biol Cryst Commun. .

Abstract

6-Hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK) catalyzes the Mg(2+)-dependent transfer of pyrophosphate from ATP to 6-hydroxymethyl-7,8-dihydropterin (HMDP), forming 6-hydroxymethyl-7,8-dihydropterin pyrophosphate, which is a critical step in the de novo folic acid-biosynthesis pathway. Diffraction-quality crystals of HPPK from the medically relevant species Staphylococcus aureus were grown in the presence of ammonium sulfate or sodium malonate and diffracted to better than 1.65 A resolution. The crystals belonged to space group P2(1), with unit-cell parameters a = 36.8, b = 76.6, c = 51.5 A, alpha = gamma = 90.0, beta = 100.2 degrees . The crystals contained two molecules per asymmetric unit, with a volume per protein weight (V(M)) of 2.04 A(3) Da(-1) and an estimated solvent content of 39.6%.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The folate pathway.
Figure 2
Figure 2
Diffraction image of a typical SaHPPK crystal.
Figure 3
Figure 3
Crystals of SaHPPK. The largest dimension of the central crystal shown is 0.143 mm.

References

    1. Adra, M. & Lawrence, K. R. (2004). Ann. Pharmacother.38, 338–341. - PubMed
    1. Babaoglu, K., Qi, J., Lee, R. E. & White, S. W. (2004). Structure, 9, 1705–1717. - PubMed
    1. Bermingham, A. & Derrick, J. P. (2002). Bioessays, 24, 637–648. - PubMed
    1. Blaszczyk, J., Shi, G., Li, Y., Yan, H. & Ji, X. (2004). Structure, 12, 467–475. - PubMed
    1. Chambers, H. F. (2005). N. Engl. J. Med.352, 1485–1487. - PubMed

MeSH terms

Substances